pSivida Corp.
(NASDAQ : PSDV)

( )
PSDV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-1.38%72.340.9%$628.84m
CELGCelgene Corporation
-2.80%127.581.1%$438.45m
AMGNAmgen Inc.
-2.09%167.811.1%$424.70m
VRTXVertex Pharmaceuticals Incorporated
-1.87%148.541.9%$372.27m
BIIBBiogen Inc.
-3.29%284.421.2%$362.89m
REGNRegeneron Pharmaceuticals, Inc.
-0.97%464.022.7%$325.42m
ALXNAlexion Pharmaceuticals, Inc.
-1.41%134.631.9%$222.67m
ILMNIllumina, Inc.
-1.52%191.203.5%$216.23m
SRPTSarepta Therapeutics, Inc.
-1.50%36.8719.8%$142.50m
INCYIncyte Corporation
-2.09%121.742.6%$132.74m
CLVSClovis Oncology, Inc.
-2.65%69.8718.0%$124.27m
AAgilent Technologies, Inc.
-2.08%60.851.5%$115.92m
TSROTESARO, Inc.
-3.49%109.0514.7%$115.83m
KITEKite Pharma, Inc.
-1.61%126.0316.1%$115.25m
BMRNBioMarin Pharmaceutical Inc.
-2.52%80.984.4%$109.09m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.